<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Eli Lilly</title>
    <link>http://www.newstin.co.uk/uk/ELI_LILLY</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Eli Lilly - News</title>
      <link>http://www.newstin.co.uk/uk/ELI_LILLY</link>
      <description>This is the demo version of Newstin RSS service. Newstin Pro RSS has a range of features to meet all your informational requirements. Receive news about 100,000 topics from 160,000 sources in the language of your choice and let Newstin customize your feeds on demand. &lt;a href="http://www.newstin.com/contact.a"&gt;Contact us&lt;/a&gt; for more information about the Newstin Pro RSS service.</description>
      <pubDate>Mon, 06 Jul 2009 00:28:45 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/ELI_LILLY</guid>
      <dc:date>2009-07-06T00:28:45Z</dc:date>
    </item>
    <item>
      <title>Payment disclosures: 'Compliance in name only'</title>
      <link />
      <description />
      <pubDate>Sun, 05 Jul 2009 18:08:47 GMT</pubDate>
      <guid />
      <dc:date>2009-07-05T18:08:47Z</dc:date>
    </item>
    <item>
      <title>'Brave' post-Lehman M&amp;A rewarded by market -study</title>
      <link />
      <description />
      <pubDate>Sun, 05 Jul 2009 23:17:00 GMT</pubDate>
      <guid />
      <dc:date>2009-07-05T23:17:00Z</dc:date>
    </item>
    <item>
      <title>The Next Wave of Open Innovation - BusinessWeek</title>
      <link />
      <description />
      <pubDate>Sun, 05 Jul 2009 20:37:28 GMT</pubDate>
      <guid />
      <dc:date>2009-07-05T20:37:28Z</dc:date>
    </item>
    <item>
      <title>Chemspec IPO Opens Strong</title>
      <link />
      <description />
      <pubDate>Sun, 05 Jul 2009 12:47:19 GMT</pubDate>
      <guid />
      <dc:date>2009-07-05T12:47:19Z</dc:date>
    </item>
    <item>
      <title>Michael Jackson's D.C. story (Politico)</title>
      <link />
      <description />
      <pubDate>Sun, 05 Jul 2009 12:01:00 GMT</pubDate>
      <guid />
      <dc:date>2009-07-05T12:01:00Z</dc:date>
    </item>
    <item>
      <title>Isis entering a new phase</title>
      <link />
      <description />
      <pubDate>Sun, 05 Jul 2009 09:00:00 GMT</pubDate>
      <guid />
      <dc:date>2009-07-05T09:00:00Z</dc:date>
    </item>
    <item>
      <title>Experiment seeks to head off Type 1 diabetes</title>
      <link />
      <description />
      <pubDate>Sat, 04 Jul 2009 20:09:50 GMT</pubDate>
      <guid />
      <dc:date>2009-07-04T20:09:50Z</dc:date>
    </item>
    <item>
      <title>Eli Lilly ‘Ghostwrote’ Articles to Market Zyprexa, Files Show</title>
      <link />
      <description />
      <pubDate>Sat, 04 Jul 2009 18:35:33 GMT</pubDate>
      <guid />
      <dc:date>2009-07-04T18:35:33Z</dc:date>
    </item>
    <item>
      <title>UPDATE 1-Novo Nordisk says Victoza cleared for EU market</title>
      <link />
      <description />
      <pubDate>Fri, 03 Jul 2009 16:49:00 GMT</pubDate>
      <guid />
      <dc:date>2009-07-03T16:49:00Z</dc:date>
    </item>
  </channel>
</rss>

